Development of novel therapeutic agents that target cancer stem cells

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500046C
Awardee
Awarding agency
Obligated
$150,000

Award facts

Opportunity
  • PHS201501 Solicitation number
Contract value 3% obligated
  • $2,414,107.00 Current, with exercised options
  • $4,378,214.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
New York, NY 10170, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Terminate for Default 2 -$150,000
Other Administrative Action 1 $0
Original award $300,000

About this award

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Lisata Therapeutics Inc. (doing business as Caladrius Biosciences) for the development of novel therapeutic agents that target cancer stem cells. The definitive, firm fixed-price contract has a total ceiling value of $4,378,214.00 and a completion date of June 20, 2018. The contract was set aside for small businesses.

Quick answers

Who was awarded contract HHSN261201500046C?

HHSN261201500046C was awarded to Lisata Therapeutics Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2015.

How much is contract HHSN261201500046C worth?

The government has obligated $150,000 on HHSN261201500046C. Its current value, with exercised options, is $2,414,107. Its potential value, with all options, is $4,378,214.

Was contract HHSN261201500046C competed?

The extent of competition for HHSN261201500046C was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award